Clinical Trials Logo

Ependymoma, Recurrent Childhood clinical trials

View clinical trials related to Ependymoma, Recurrent Childhood.

Filter by:
  • None
  • Page 1

NCT ID: NCT04408092 Completed - Ependymoma Clinical Trials

Study of the Effect of GM-CSF on Macrophages in Ependymoma

Start date: June 25, 2013
Phase: Early Phase 1
Study type: Interventional

This study plans to learn more about the use of Granulocyte Macrophage Colony Stimulation Factor (GM-CSF) on ependymoma tumors. The use of GM-CSF is a potential way of increasing the infiltration of immune cells and this study is looking at whether or not this will improve the outcome of patients with an ependymoma

NCT ID: NCT03206021 Completed - Clinical trials for Childhood Solid Tumor

COZMOS:Phase I/Ib Trial of Combined 5'Azacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain/Solid Tumors

COZMOS
Start date: August 1, 2017
Phase: Phase 1
Study type: Interventional

Many pediatric brain and solid tumors have altered epigenetic landscapes, and altered DNA methylation. As such this study is a Phase I/Ib study of combined 5'Azacitidine with an escalating dose of carboplatin for all recurrent/refractory pediatric brain and solid tumors. The phase I component will establish with maximum tolerated dose of carboplatin with azacytidine. An expansion cohort will be recruited of up to 30 patients will follow consisting of 20 recurrent posterior fossa ependymoma and 10 recurrent supratentorial ependymoma.